Power Law company profile

SpringWorks Therapeutics

Biotech & Life Sciences · New York City, United States · Founded 2017 · IPO 2019 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$3.26B

Market cap · 2026

Revenue

$192M

Latest reported FY

Investors

12 investors on SpringWorks Therapeutics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 4 investors entered at this stage

Series B+ 8 investors entered at this stage

Global footprint

Where SpringWorks Therapeutics has talent and traffic

AI talent share

0.3% of workforce is AI talent
(1 of 400 staff)

Core AI00%

Other AI10.25%

Non-AI workforce39999.75%

Web traffic by country

9.2K monthly visits
across markets

🇺🇸 United States77.2%

🇮🇳 India18.5%

🇩🇪 Germany4.3%

Top 3 markets shown

Patent intelligence

$23M patent portfolio · 60 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with topic prominence vs same-sector peers.

Estimated portfolio value

$23M

0.71% of market cap · 4.8× smaller than top peer Bavarian Nordic ($111M)

60 active patent families

Where SpringWorks Therapeutics innovates CarcinosisPharmacologyOncologyPharmaceutical medicineInternal medicine

Tech-focus vs peers

Where SpringWorks Therapeutics concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across SpringWorks Therapeutics and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See SpringWorks Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo